With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates AstraZeneca stands as one of the world’s premier biotechnology companies, our mission is centered on delivering life-changing products that advance world health and help fight and cure disease.  If you’re inspired by the possibilities of science to change lives and you thrive when making brave decisions – join us.

We’re constantly pushing the boundaries of science to deliver life-changing medicines to patients, with a passion for discovery and a pipeline to show for it. We’re pioneering innovative research and exploring novel pathways across key therapeutic areas including oncology, respiratory, inflammation and autoimmunity, cardiovascular and metabolic disease, and infection and vaccines. And we’re industry-leading in immunology, protein engineering and translational science. We offer a unique and strong collaborative network as part of the AstraZeneca family, as together we explore synergies between small and large molecules.

AstraZeneca has a dynamic environment that fosters collaboration and innovation. We attract top minds, and we nurture and build top talent.

Position Summary:

We are seeking well-trained clinicians with strong leadership skills who are driven by science and the desire to develop novel Immuno-Oncology, Cell Therapy, Anti-body Drug Conjugate, Tumor Driver, DNA Damage Response and Epigenetics therapies for cancer patients, and who has a mastery of the drug development process (especially early phase clinical trials), protocol writing & study conduct, data review and reconciliation, the principles of translational medicine, and what it takes to lead teams successfully.   This individual will have the opportunity for growth and development while working in a vibrant environment.

Educational Requirements:

•             MD or international equivalent is required

•             Medical Oncology specialty and sub-specialty training is required, Board Certification is preferred.

Experience:

•             Clinical or research experience (in an academic, pharmaceutical or CRO environment) related to the design and/or conduct of clinical studies in oncology and/or hematology is required.

•             Immuno-therapy experience preferred.  Cell therapy experience desirable but not critical.

•             Director- At least 2-5 years of experience in clinical research and/or Oncology drug development in pharmaceutical or CRO environment.